Natco Group company information, Employees & Contact Information

Natco Pharma launches generic drug with 180-day exclusivity in US The Economic Times

Natco highlights U.S. manufacturing strength, launches custom rugs program Home Textiles Today

Natco Pharma gains after U.S. FDA classification of Hyderabad formulations facility as VAI The Hindu

Natco Hypertension generic obtains marketing approval in US ET Pharma

Natco Pharma, Lupen launch Bosentan tablets in US with 180-day exclusivity BusinessLine

US Has No Alternative To Indian Generic Drugs: Natco Pharma CEO Rajiv Nannapaneni ETV Bharat

NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit Business Standard

Natco CEO says scouting for buyouts larger than Adcock to boost non-US revenue Moneycontrol

Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO The Hindu

Natco Pharma Limited Completes Transition of DASH Pharmaceuticals into Natco Pharma USA, Furthering Strategic Presence in the United States Business Wire

Trump tariffs on pharma: Natco Pharma is scouting for acquisitions in US, RoW markets BusinessLine

NATCO Pharma launches generic Bosentan tablets for oral suspension in the United States Express Pharma

U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad The Hindu

Lupin and NATCO launch generic Bosentan tablets in U.S. ET Pharma

Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulator The Economic Times

Natco Pharma’s API plant in Hyderabad gets U.S. FDA observation The Hindu

Natco Pharma Q1 results: Net profit declines 28% on U.S. pricing pressure; declares interim dividend The Hindu

Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO The Hindu

U.S. FDA nod for Natco Pharma’s generic of Novartis drug The Hindu

Complaint filed against Natco Pharma in US by Fresenius Kabi The Economic Times

Natco Pharma launches generic drug for PAH in the U.S. The Hindu

Natco Pharma shares rise 4% on settlement order in US patent case over generic Ozempic Moneycontrol

Lupin and Natco secure US FDA approval for generic Bosentan tablets for oral suspension Express Pharma

U.S. FDA issues warning letter to Natco over facility near Hyderabad The Hindu

Natco Pharma shares gain after settlement in US patent litigation on generic Ozempic CNBC TV18

Natco Pharma, others sued in US for generic cancer drug Moneycontrol

Natco Pharma Launches Bosentan Tablets in U.S. with 180-Day Exclusivity scanx.trade

India’s Natco Pharma sued in US The Hans India

USFDA pulls up Natco Pharma for several violations at Telangana plant Business Standard

Lupin, Glenmark and Natco Pharma recall drugs in US market due to manufacturing issues financialexpress.com

NATCO launches first generic version of Nexavar Tablets in the US Indian Pharma Post

Natco Pharma, Cipla, Other Pharma Stocks Surge Up To 4% As US Authorities Aim To Cut Drug Prices News18

Lupin and Natco receives USFDA approval for Bosentan Tablets for Oral Suspension Business Standard

NATCO announces ANDA filing for generic olaparib tablets in US Express Pharma

Natco board approves proposal to acquire US-based pharma company Business Standard

Natco Pharma seeks U.S. FDA nod for copy of Pfizer’s migraine drug, faces lawsuit The Hindu

Mylan and Novo Nordisk settle US generic Ozempic dispute, Natco Pharma poised for market entry CNBC TV18

NATCO Pharma Limited invests around US$ 2 million in Cellogen Therapeutics ET HealthWorld

Natco launches additional strengths of generic version of Revlimid in US Business Standard

Natco Pharma unveils additional strengths of generic Revlimid in U.S. The Hindu

Pharma stocks led by Natco, Wockhardt fall up to 5% after US tariffs on generic, patented drugs CNBC TV18

How Natco Pharma put US drug giant Eli Lilly under pressure for COVID-19 drug through compulsory licensing... Moneycontrol

Natco Pharma Faces US Lawsuit Over Diazepam Injection Rediff MoneyWiz

Natco Pharma Shares Up 3% After Settling US Patent Litigation on Generic Ozempic Equitypandit

Natco Pharma’s Hyderabad API plant receives EIR from U.S. FDA The Hindu

US court rejects Natco Pharma partner’s appeal in patent litigation CNBC TV18

Natco Pharma launches first generic version of Revlimid in US Moneycontrol

Natco gets US FDA approval for Carfilzomib vials Express Pharma

NATCO gets US FDA approval for Pomalidomide capsules Express Pharma

NATCO gets tentative US FDA approval for Ibrutinib tablets Express Pharma

Natco Pharma launches first generic of Nexavar in the US BusinessLine

Natco takes on US co over insecticide products in India Times of India

Natco settles patent litigation in the U.S. The Hindu

Hyderabad Based NATCO Pharma Gets FDA Approval For Marketing Bosentan Tablets In US INDToday